--- slug: pt-141-selank-ssri title: "PT-141 + Selank for SSRI Users: Evidence Review" kind: source_ledger status: published hash: 461a292e2c77ea95035ce09acc2509eea062742c7d6e89d429b57f43ade5dd0e created: 2026-06-29T13:25:03.815Z updated: 2026-10-08T11:50:12.983Z summary: "PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically" tags: [] above: [] below: [] adjacent: [] nested: [] --- # PT-141 + Selank for SSRI Users: Evidence Review *PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically* ## PT-141 (Bremelanotide) Evidence PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo. Human trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users. ## Selank Evidence Selank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal. Additional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist. ## Mechanisms (Mechanistic Tier) PT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways. Selank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies. ## Combination and SSRI Context No human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative. ## Evidence Summary - PT-141: Human (FDA approval and phase 3 trials for HSDD). - Selank: Human (Russian clinical trials for GAD; limited Western validation). - SSRI-specific effects or stack: Speculative (no supporting data). --- Related: [Selank](/a/selank) · [PT-141](/a/pt-141) ![[selank]] ![[pt-141]] ## Facts ```json { "converted_from": "markdown", "original_updated": "2026-06-29T21:17:02.152Z", "register": "source_ledger", "category": null } ``` ## Sources 1. [Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder](https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/) — “Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.” (sha256 62782238eda68692) 2. [VYLEESI Prescribing Information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf) — “VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).” (sha256 cff2b1f08b0ef83e) 3. [Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission](https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/) — “Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.” (sha256 6ef04632b0a53ed5) 4. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia](https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia) — “The effect of selank (30 patients) was compared to that of medazepam (32 patients).” (sha256 ef73937a87feaca7) 5. [Bremelanotide: Uses, Interactions, Mechanism of Action](https://go.drugbank.com/drugs/DB11653) — “Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.” (sha256 f84cabda855477ea) 6. [Selank peptides, Can you take it with escitaloprám.](https://www.reddit.com/r/PeptideForum/comments/1mo483x/selank_peptides_can_you_take_it_with_escitalopr%C3%A1m/) — “BUT I am on 5mg of escitalopram and Selank and my Dr said it was fine. So, while my case is similar, its not exactly the same but similar.” (sha256 1c40961a12b67ede) 7. [Anyone taking Semax and Selank. What is your experience](https://www.reddit.com/r/PeptideForum/comments/1qjtdfv/anyone_taking_semax_and_selank_what_is_your/) — “I love the S&S blend off crafters. It’s pretty good as I have anxiety And take Zoloft. It works with my current prescription.” (sha256 22dd11f818e13cb0) 8. [Full PT-141 Guide](https://www.reddit.com/r/BodyHackGuide/comments/1qt7vsg/full_pt141_guide/) — “This is why people use it for: • Low libido • Performance anxiety • SSRI sexual sides • “Everything works but I don’t feel it”” (sha256 b58ace1daaa523b6) 9. [PT-141 - Peptide Affect](https://peptideaffect.com/pt-141/) — “PT-141 + Selank – Calm and Desire Balance **Summary:** A calming, balanced stack for those who experience anxiety or performance-related inhibition. **Why it works:** Selank reduces anxiety by supporting GABA signaling in the brain. This can help relax the nervous system and remove emotional blocks to desire. PT-141 + SSRIs or Dopaminergic Medications – Unpredictable Mood Interactions **Summary:** Combining PT-141 with prescription mood medications (especially SSRIs or dopam” (sha256 14a557f7e83ca25b) 10. [Peptides With Psychiatric Medications: A Psychiatrists Guide](https://thebh.us/blog/peptides-with-psychiatric-medications/) — “Selank is the more cautious case. The peptide slows enzymatic breakdown of serotonin in certain brain regions, which increases serotonin availability through a different mechanism than an SSRI’s reuptake blockade, but in the same direction. The combination is not equivalent to stacking two direct serotonergic drugs, and it is not the same as combining an SSRI with an MAOI (the classic high-risk pairing for serotonin syndrome). It is, however, not zero either.” (sha256 b8f91c4667608e6f) 11. [Has anyone tried PT-141, selank, or semax?](https://www.reddit.com/r/PeptideDiscussion/comments/1ra5gba/has_anyone_tried_pt141_selank_or_semax/) — “Has anyone tried PT-141 , selank , or semax? These are kind of the brain stimulating peptides that are supposed to be fast acting. I was ...” (sha256 e2229c4cffc258a1) 12. [Love Potion (PT141-Selank-Oxytocin) nasal spray](https://glp1forum.com/threads/love-potion-pt141-selank-oxytocin-nasal-spray.18608/) — “Minus oxytocin (personally, subq was a nightmare), selank and PT-141 seem better to me at least, subcutaneous. First time, 0.6 mg PT-141 .” (sha256 8e1cc1222c11a624)